Codiak BioSciences, Inc. Deferred Revenue (Non-Current)
Codiak BioSciences, Inc. had Deferred Revenue (Non-Current) of $17.32 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2022-11-03
- 2022-09-30: Deferred Revenue, Noncurrent $17.32M.
- 2022-06-30: Deferred Revenue, Noncurrent $17.34M.
- 2022-03-31: Deferred Revenue, Noncurrent $30.50M.
- 2021-12-31: Deferred Revenue, Noncurrent $30.69M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2022-09-30 | $17.32M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $17.34M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $30.50M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $30.69M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $41.39M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $41.75M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $46.01M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $57.42M 10-K · filed 2022-03-10 |
| 2020-09-30 | $58.07M 10-Q · filed 2020-11-19 |
| 2019-12-31 | $54.87M 10-K · filed 2021-03-17 |